NIH Public Access Author Manuscript Clin Pediatr Emerg Med
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Lung Pathology: Embryologic Abnormalities
Chapter2C Lung Pathology: Embryologic Abnormalities Content and Objectives Pulmonary Sequestration 2C-3 Chest X-ray Findings in Arteriovenous Malformation of the Great Vein of Galen 2C-7 Situs Inversus Totalis 2C-10 Congenital Cystic Adenomatoid Malformation of the Lung 2C-14 VATER Association 2C-20 Extralobar Sequestration with Congenital Diaphragmatic Hernia: A Complicated Case Study 2C-24 Congenital Chylothorax: A Case Study 2C-37 Continuing Nursing Education Test CNE-1 Objectives: 1. Explain how the diagnosis of pulmonary sequestration is made. 2. Discuss the types of imaging studies used to diagnose AVM of the great vein of Galen. 3. Describe how imaging studies are used to treat AVM. 4. Explain how situs inversus totalis is diagnosed. 5. Discuss the differential diagnosis of congenital cystic adenomatoid malformation. (continued) Neonatal Radiology Basics Lung Pathology: Embryologic Abnormalities 2C-1 6. Describe the diagnosis work-up for VATER association. 7. Explain the three classifications of pulmonary sequestration. 8. Discuss the diagnostic procedures for congenital chylothorax. 2C-2 Lung Pathology: Embryologic Abnormalities Neonatal Radiology Basics Chapter2C Lung Pathology: Embryologic Abnormalities EDITOR Carol Trotter, PhD, RN, NNP-BC Pulmonary Sequestration pulmonary sequestrations is cited as the 1902 theory of Eppinger and Schauenstein.4 The two postulated an accessory he clinician frequently cares for infants who present foregut tracheobronchia budding distal to the normal buds, Twith respiratory distress and/or abnormal chest x-ray with caudal migration giving rise to the sequestered tissue. The findings of undetermined etiology. One of the essential com- type of sequestration, intralobar or extralobar, would depend ponents in the process of patient evaluation is consideration on the timing of the accessory foregut budding (Figure 2C-1). -
Journal of Turgut Ozal Medical Center
OLGU SUNUMU/CASE REPORT J Turgut Ozal Med Cent 2015;22(3):193-6 Journal of Turgut Ozal Medical Center www.jtomc.org The Case of a Patient with Concomitant Popliteal Artery and Ascending Aortic Aneurysm Who Presented with the Blue Toe Syndrome Tevfik Güneş, İhsan Alur, Serkan Girgin, Bilgin Emrecan Pamukkale University, Faculty of Medicine, Department of Cardiovascular Surgery, Denizli, Turkey Abstract Popliteal artery aneurysms (PAAs) are rare though these aneurysms are the most frequently encountered peripheral arterial aneurysms. In this article, we present the treatment of a patient who simultaneously had bilateral popliteal artery and ascending aortic aneurysm but was admitted to the emergency room due to the blue toe syndrome. A 72-old-year female was admitted to the hospital with left lower extremity pain and cyanosis in her toe. Bilateral popliteal artery and ascending aortic aneurysm were observed on computed tomography. Aneurysmectomy and femoropopliteal bypass was performed primarily to the left popliteal artery owing to ischemia. Two months later, we performed valve and ascending aorta replacement followed by right popliteal aneurysmectomy and femoropopliteal bypass 16 months later. In conclusion, since other arterial aneurysms can be simultaneously observed with popliteal artery aneurysm, it is very important to scan whole main arterial system when PAA is evaluated. Key Words: Popliteal Artery; Aorta; Aneurysm; Embolism. Blue Toe Sendromu ile Başvuran Popliteal Arter ve Asendan Aort Anevrizmalı Hasta Özet Popliteal arter anevrizmaları (PAA) nadir görülen patolojilerdir, fakat periferik arter anevrizmaları arasında en sık karşılaşılanıdır. Bu yazıda blue toe sendromu ile başvuran bilateral popliteal arter ve asendan aort anevrizması saptanan hastanın aşamalı tedavisi sunulmaktadır. -
Approach to Cyanosis in a Neonate.Pdf
PedsCases Podcast Scripts This podcast can be accessed at www.pedscases.com, Apple Podcasting, Spotify, or your favourite podcasting app. Approach to Cyanosis in a Neonate Developed by Michelle Fric and Dr. Georgeta Apostol for PedsCases.com. June 29, 2020 Introduction Hello, and welcome to this pedscases podcast on an approach to cyanosis in a neonate. My name is Michelle Fric and I am a fourth-year medical student at the University of Alberta. This podcast was made in collaboration with Dr. Georgeta Apostol, a general pediatrician at the Royal Alexandra Hospital Pediatrics Clinic in Edmonton, Alberta. Cyanosis refers to a bluish discoloration of the skin or mucous membranes and is a common finding in newborns. It is a clinical manifestation of the desaturation of arterial or capillary blood and may indicate serious hemodynamic instability. It is important to have an approach to cyanosis, as it can be your only sign of a life-threatening illness. The goal of this podcast is to develop this approach to a cyanotic newborn with a focus on these can’t miss diagnoses. After listening to this podcast, the learner should be able to: 1. Define cyanosis 2. Assess and recognize a cyanotic infant 3. Develop a differential diagnosis 4. Identify immediate investigations and management for a cyanotic infant Background Cyanosis can be further broken down into peripheral and central cyanosis. It is important to distinguish these as it can help you to formulate a differential diagnosis and identify cases that are life-threatening. Peripheral cyanosis affects the distal extremities resulting in blue color of the hands and feet, while the rest of the body remains pinkish and well perfused. -
Extralobar Pulmonary Sequestration Infected with Mycobacterium Gordonae
Brief Communications Extralobar pulmonary sequestration infected with Mycobacterium gordonae Yukio Umeda, MD, PhD,a Yukihiro Matsuno, MD, PhD,a Matsuhisa Imaizumi, MD, PhD,a Yoshio Mori, MD, PhD,a Hitoshi Iwata, MD, PhD,b and Hiroshi Takiya, MD, PhD,a Gifu, Japan Pulmonary sequestration is a malformation composed of lung was found except around the left lower pulmonary dysplastic lung tissue without normal communication with vein. We diagnosed it as extralobar sequestration and the tracheobronchial tree and with an anomalous systemic planned a simple excision of the sequestrated lung. We di- arterial supply.1 Few cases of pulmonary sequestration in- vided the aberrant artery and drainage vein and excised the fected with tuberculous or nontuberculous mycobacterium sequestrated lung using a linear stapler. The postoperative have been reported.2-4 However, all of those reports were course was uneventful. of intralobar pulmonary sequestrations. In the present article, Histopathologic study revealed destruction of alveolar we describe the first case of extralobar sequestration infected and reconstruction of respiratory epithelium within its own with Mycobacterium gordonae. pleura. The alveolar spaces were filled by mucoid or mono- nuclear cells. Caseating epithelioid granulomas and Lan- ghans’ giant cells were also observed (Figure 2). The CLINICAL SUMMARY diagnosis was of an extralobar pulmonary sequestration in- In August of 2005, a 72-year-old woman was referred to fected with Mycobacterium. M. gordonae was identified the Gifu Prefectural General Medical Center for abnormal from the culture of preoperatively collected sputum and sur- shadow on chest x-ray. Contrast media-enhanced com- gical specimen by the DNA–DNA hybridization method. -
Recurrent Pneumonia (Recurrent Lower Respiratory Tract Infections)
Recurrent Pneumonia (Recurrent lower respiratory tract infections) Guideline developed by Gulnur Com, MD, and Jeanne Velasco, MD in collaboration with the ANGELS team. Last reviewed by Jeanne Velasco, MD, on May 15, 2017. Key Points A single episode of uncomplicated pneumonia in an otherwise healthy child does not require investigation. Recurrent pneumonia is not an uncommon presenting symptom in general pediatric practice and one of the most common reasons for referral to pediatric pulmonologists. Recurrent pneumonia is usually defined as ≥2 episodes of pneumonia in a year or ≥3 in life.1 Many children with recurrent pneumonia do not need a full diagnostic work up, either because pneumonia episodes are not frequent or severe enough or because eventually children become asymptomatic. Evaluation of children with recurrent pneumonias begins by taking a careful history, an examination while the child is sick, and confirmation that the child is truly experiencing recurrent pneumonia. The majority of recurrent pneumonia causes in children have predictable risk factors (e.g., psychomotor retardation with feeding problems). Extensive investigations may not identify an underlying cause in up to 30% of children with recurrent pneumonia.1 The initial step in evaluating a child with recurrent respiratory symptoms includes distinguishing between recurrent wheezing versus recurrent infections. Studies show that asthma is being over diagnosed in children with recurrent respiratory symptoms. Patients with atypical asthma that does not respond to therapy should be investigated further. The evaluation of children with recurrent pneumonia should not be focused only on the respiratory tract. 1 Investigation for other organ system involvement may help for ultimate diagnosis (e.g., cystic fibrosis). -
Dermatologic Aspects of Fabry Disease ª the Author(S) 2016 DOI: 10.1177/2326409816661353 Iem.Sagepub.Com
Original Article Journal of Inborn Errors of Metabolism & Screening 2016, Volume 4: 1–7 Dermatologic Aspects of Fabry Disease ª The Author(s) 2016 DOI: 10.1177/2326409816661353 iem.sagepub.com Paula C. Luna, MD1,2, Paula Boggio, MD2, and Margarita Larralde, MD, PhD1,2 Abstract Isolated angiokeratomas (AKs) are common cutaneous lesions, generally deemed unworthy of further investigation. In contrast, diffuse AKs should alert the physician to a possible diagnosis of Fabry disease (FD). Angiokeratomas often do not appear until adolescence or young adulthood. The number of lesions and the extension over the body increase progressively with time, so that generalization and mucosal involvement are frequent. Although rare, FD remains an important diagnosis to consider in patients with AKs, with or without familial history. Dermatologists must have a high index of suspicion, especially when skin features are associated with other earlier symptoms such as acroparesthesia, hypohidrosis, or heat intolerance. Once the diagnosis is established, prompt screening of family members should be performed. In all cases, a multidisciplinary team is necessary for the long-term follow-up and treatment. Keywords Fabry disease, angiokeratomas, lysosomal storage disorders Introduction Diffuse AKs are characterized by the presence of multiple lesions that affect more than 1 area of the skin. Although any Fabry disease (FD, also known as Anderson-Fabry disease or region of the skin can be affected, lesions usually localize to the angiokeratoma corporis diffusum [ACD]) is a rare X-linked bathing suit area (from the umbilicus to the upper thighs); this disease caused by the partial or complete deficiency of a lyso- phenotype is known as ACD. -
Cocats 4 (Pdf)
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 65, NO. 17, 2015 ª 2015 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 0735-1097/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jacc.2015.03.017 TRAINING STATEMENT ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3) A Report of the ACC Competency Management Committee Task Force Introduction/Steering Committee Task Force 3: Training in Electrocardiography, Members Jonathan L. Halperin, MD, FACC Ambulatory Electrocardiography, and Exercise Testing (and Society Eric S. Williams, MD, MACC Gary J. Balady, MD, FACC, Chair Representation) Valentin Fuster, MD, PHD, MACC Vincent J. Bufalino, MD, FACC Martha Gulati, MD, MS, FACC Task Force 1: Training in Ambulatory, Jeffrey T. Kuvin, MD, FACC Consultative, and Longitudinal Cardiovascular Care Lisa A. Mendes, MD, FACC Valentin Fuster, MD, PHD, MACC, Co-Chair Joseph L. Schuller, MD Jonathan L. Halperin, MD, FACC, Co-Chair Eric S. Williams, MD, MACC, Co-Chair Task Force 4: Training in Multimodality Imaging Nancy R. Cho, MD, FACC Jagat Narula, MD, PHD, MACC, Chair William F. Iobst, MD* Y.S. Chandrashekhar, MD, FACC Debabrata Mukherjee, MD, FACC Vasken Dilsizian, MD, FACC Prashant Vaishnava, MD Mario J. Garcia, MD, FACC Christopher M. Kramer, MD, FACC Task Force 2: Training in Preventive Shaista Malik, MD, PHD, FACC Cardiovascular Medicine Thomas Ryan, MD, FACC Sidney C. Smith, JR, MD, FACC, Chair Soma Sen, MBBS, FACC Vera Bittner, MD, FACC Joseph C. Wu, MD, PHD, FACC J. Michael Gaziano, MD, FACC John C. Giacomini, MD, FACC Quinn R. Pack, MD Donna M. -
Adult Outcome of Congenital Lower Respiratory Tract Malformations M S Zach, E Eber
500 Arch Dis Child: first published as 10.1136/adc.87.6.500 on 1 December 2002. Downloaded from PAEDIATRIC ORIGINS OF ADULT LUNG DISEASES Series editors: P Sly, S Stick Adult outcome of congenital lower respiratory tract malformations M S Zach, E Eber ............................................................................................................................. Arch Dis Child 2002;87:500–505 ongenital malformations of the lower respiratory tract relevant studies have shown absence of the normal peristaltic are usually diagnosed and managed in the newborn wave, atonia, and pooling of oesophageal contents.89 Cperiod, in infancy, or in childhood. To what extent The clinical course in the first years after repair of TOF is should the adult pulmonologist be experienced in this often characterised by a high incidence of chronic respiratory predominantly paediatric field? symptoms.910 The most typical of these is a brassy, seal-like There are three ways in which an adult physician may be cough that stems from the residual tracheomalacia. While this confronted with this spectrum of disorders. The most frequent “TOF cough” is both impressive and harmless per se, recurrent type of encounter will be a former paediatric patient, now bronchitis and pneumonitis are also frequently observed.711In reaching adulthood, with the history of a surgically treated rare cases, however, tracheomalacia can be severe enough to respiratory malformation; in some of these patients the early cause life threatening apnoeic spells.712 These respiratory loss of lung tissue raises questions of residual damage and symptoms tend to decrease in both frequency and severity compensatory growth. Secondly, there is an increasing with age, and most patients have few or no respiratory number of children in whom paediatric pulmonologists treat complaints by the time they reach adulthood.13 14 respiratory malformations expectantly; these patients eventu- The entire spectrum of residual respiratory morbidity after ally become adults with their malformation still in place. -
Diffuse Microvascular Pulmonary Thrombosis Associated with Primary Antiphospholipid Antibody Syndrome
Eur Respir J 1997; 10: 727–730 Copyright ERS Journals Ltd 1997 DOI: 10.1183/09031936.97.10030727 European Respiratory Journal Printed in UK - all rights reserved ISSN 0903 - 1936 CASE STUDY Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndrome M. Maggiorini*, A. Knoblauch**, J. Schneider+, E.W. Russi* Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid Depts of *Internal Medicine, and +Pathology, antibody syndrome. M. Maggiorini, A. Knoblauch, J. Schneider, E.W. Russi. ©ERS University Hospital, Zurich, Switzerland. Journals Ltd 1997. **Pneumology Division, Kantonsspital, St. ABSTRACT: Thromboembolism is a well-known complication of the hypercoag- Gallen, Switzerland. ulable state associated with anitphospholipid (aPL) antibodies. Acute respiratory Correspondence: M. Maggiorini failure (ARF) with diffuse pulmonary infiltrates has been reported in only a few Dept of Internal Medicine patients with aPL antibodies. University Hospital We describe a 49 year old patient with spiking fever, livedo reticularis, mild Ramistrasse 100 haemoptysis and ARF. Chest radiography revealed diffuse bilateral pulmonary infil- 8091 Zurich trates, and high resolution computed tomography (CT) revealed patchy distribu- Switzerland tion of areas of ground-glass attenuations. Pulmonary emboli were excluded with angiography. Lung biopsy revealed diffuse microvascular thrombosis, without cap- Keywords: Acute respiratory failure illaritis. High serum levels of anticardiolipin (aCL) antibodies -
Occlusive Shrinkage of Ovation Endograft Presenting As Acute Lower Limb Ischemia
Case Report AORTA, February 2017, Volume 5, Issue 1:21-26 Received: July 06, 2016 DOI: http://dx.doi.org/10.12945/j.aorta.2017.16.041 Accepted: October 28, 2016 Published online: February 2017 Occlusive Shrinkage of Ovation Endograft Presenting as Acute Lower Limb Ischemia Effective Endovascular Management Paolo Bianchi, MD1, Filippo Scalise, MD, FACC, FESC2, Andrea Mortara, MD3, Guido Lanzillo, MD, FECTS4, Giuseppe Scardina, MD3, Santi Trimarchi, MD, PhD5, Gianfranco Parati, MD, FESC6,7, Valerio Tolva, MD, PhD, FEBVS1,6* 1 Department of Vascular Surgery, Centro Cuore, Policlinico di Monza, Monza, Italy 2 Department of Interventional Cardiology, Centro Cuore, Policlinico di Monza, Monza, Italy 3 Department of Cardiology, Centro Cuore, Policlinico di Monza, Monza, Italy 4 Department of Cardiac Surgery, Centro Cuore, Policlinico di Monza, Monza, Italy 5 Department of Vascular Surgery, Policlinico San Donato IRCCS, San Donato Milanese, Italy 6 Department of Health Sciences, University of Milano-Bicocca, Milan, Italy 7 Istituto Auxologico Italiano IRCCS, San Luca Hospital, Milano, Italy Abstract shrinkage of proximal rings in the Ovation trivascular endograft. Angiographic and intravascular ultrasound The aim of this report is to describe the imaging and findings showed that covered stenting is effective and successful treatment of an acute shrinkage of the Ova- that the ring polymer is safely moldable. tion Abdominal Stent Graft System. The Ovation Prime Copyright © 2017 Science International Corp. system utilizes a polymer-filled sealing ring that is cast in situ at the margin of the aneurysm; however, the re- Key Words: sidual endograft inner volume after ring filling may re- duce volume and graft flow. -
Erythromelalgia Misdiagnosed As Cellulitis
CONTINUING MEDICAL EDUCATION Erythromelalgia Misdiagnosed as Cellulitis LT Mark Eaton, MC, USNR; LCDR Sean Murphy, MC, USNR GOAL To understand erythromelalgia OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Describe the clinical presentation of erythromelalgia in patients. 2. Explain the pathophysiology of erythromelalgia. 3. Discuss the treatment options for erythromelalgia. CME Test on page 32. This article has been peer reviewed and is accredited by the ACCME to provide continuing approved by Michael Fisher, MD, Professor of medical education for physicians. Medicine, Albert Einstein College of Medicine. Albert Einstein College of Medicine designates Review date: December 2004. this educational activity for a maximum of 1 This activity has been planned and implemented category 1 credit toward the AMA Physician’s in accordance with the Essential Areas and Policies Recognition Award. Each physician should of the Accreditation Council for Continuing Medical claim only that credit that he/she actually spent Education through the joint sponsorship of Albert in the activity. Einstein College of Medicine and Quadrant This activity has been planned and produced in HealthCom, Inc. Albert Einstein College of Medicine accordance with ACCME Essentials. Drs. Eaton and Murphy report no conflict of interest. The authors report off-label use of aspirin, gabapentin, heparin, lidocaine patches, misoprostol, serotonin reuptake inhibitors, ticlopidine, topical capsaicin, tricyclic antidepressants, and warfarin for the treatment of erythromelalgia. Dr. Fisher reports no conflict of interest. This case report examines the presentation of a Treatments target symptom alleviation, as well as patient with erythromelalgia that was misdiag- diagnosis and treatment of causative factors. -
Erythromelalgia Presentation and Outcome in 168 Patients
STUDY Natural History of Erythromelalgia Presentation and Outcome in 168 Patients Mark D. P. Davis, MB, MRCPI; W. Michael O’Fallon, PhD; Roy S. Rogers III, MD; Thom W. Rooke, MD Objective: To describe the demographics, presenta- male, and 46 (27.4%) were male. At presentation, the pa- tion, and outcome in patients with erythromelalgia—a tients’ mean age was 55.8 years (age range, 5-91 years). rare and poorly understood clinical syndrome defined by Symptoms had been present since childhood in 7 pa- the triad of red, hot, painful extremities. tients (4.2%). Six patients (3.6%) had a first-degree rela- tive with erythromelalgia. Symptoms were intermittent Design: Retrospective medical record review with fol- in 163 patients (97.0%) and constant in 5 (3.0%). Symp- low-up by survey questionnaire. toms predominantly involved feet (148 patients [88.1%]) and hands (43 patients [25.6%]). Kaplan-Meier sur- Setting: Large tertiary care medical center. vival curves revealed a significant decrease in survival com- pared with that expected in persons of similar age and Subjects: Patients with erythromelalgia examined at the of the same sex (P,.001). After a mean follow-up of 8.7 Mayo Clinic, Rochester, Minn, between 1970 and 1994. years (range, 1.3-20 years), 30 patients (31.9%) re- ported worsening of, 25 (26.6%) no change in, 29 (30.9%) Intervention: The medical records of 168 patients were improvement in, and 10 (10.6%) complete resolution of analyzed. Follow-up data, which consisted of answers to the symptoms. On a standard health status question- 2 survey questionnaires or the most recent information naire, scores for all but one of the health domains were in the medical record from patients still alive and death significantly diminished in comparison with those in the certificates or reports of death for those deceased pa- US general population.